This Article supports SDG 3 by using modelling to estimate the impact of immigration on hepatitis B prevalence in the USA, in order to more accurately assess the hepatitis B burden, which might not be accurately measured by national serosurveys. The study found a significantly higher burden of hepatitis B (1.8 million cases), significantly higher than that found in national serosurveys.
This Article supports SDG 3 by showing that an HCV testing (point-of-care) and treatment programme implemented in users of a supervised drug cosumption service in Canada was beneficial, with a large degree of positive testing, testing acceptance, and treatment engagement. The study suggests that on-site point of care testing and treatment for HCV in supervised consumption services is effective in reaching this population
This Article supports Sustainable Development Goal 3 by highlighting differential effects of sleep disturbances on resting-state neural activity in patients on the Alzheimer's disease spectrum relative to healthy adults, suggesting a key role of sleep disturbances in the neurophysiological changes seen in Alzheimer's disease, with implications for basic research and clinical intervention.
This Article supports Sustainable Development Goal 3 by describing a cohort characterization model for Alzheimer’s Disease built on medications and diagnoses data that are widely available in a structured format in electronic health records (EHRs), showing that standard machine learning applied to sequences of EHR data can produce scalable computational characterization of Alzheimer’s disease cohorts.
Elsevier,
Overcoming Obstacles in Drug Discovery and Development, Surmounting the Insurmountable—Case Studies for Critical Thinking 2023
Racial and ethnic disparities among clinical trial participants is a long-standing issue demanding attention in the research community as advances in precision medicine increase. This exclusion from clinical trial enrollment has tangible consequences, preventing traditionally underserved populations from benefitting from health innovation and cutting-edge technologies. Aggregation of populations into a generalized treatment population lends to the evident healthcare inequities we see today and support SDG3
The fallout of Target's response to backlash for its 2023 Pride Month merchandise has inspired a greater conversation about employer social justice efforts. This article provides five ways employers can respond to avoid a similar outcome, and in so doing promote SDGs 8 and 10.
This Viewpoint supports SDGs 3 and 10 by examining, in view of the potential termination of the Deferred Action for Childhood Arrivals programme in the USA, the implications for government funding of health care for immigrant populations such as undocumented migrants, and the importance of ensuring equitable access to health care for all population groups.
With AI-driven labor market transformations being affected by economic troubles and other factors, this article explores the strategies leaders are using to help workers navigate these changes. Specifically, leaders are stepping up investing in at least four strategies to prepare workers for the prevailing disruption and empower them to successfully navigate the change while ensuring healthy work cultures and compelling work opportunities for all.
This study provides a better understanding of the burrowing behaviour of the sub-legal size clams discarded on the sediment after being disturbed and contributes important data to improve practices for minimizing mortality of dislodged clams that are discarded on the sediment surface.
This Article supports SDG 3 by analysing follow-up data from over 200 000 people with HIV from 20 cohorts in North America and Europe who had started ART up to 20 years previously, and showing that estimated life expectancy for people with HIV on long-term ART with high CD4 cell counts is only a few years lower than that in the general population, irrespective of when ART was started.
